Welcome to NeurologyLive® 's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive 's widespread coverage in ...
CSPC Pharma announced that the group has presented, in the form of a rapid oral presentation at the 2026 International ...
A cross-sectional study of 16,267 insulin-requiring adults across 40 federally qualified health centers in 17 states found ...
A study suggests that a reduced dose of enfortumab vedotin may lower toxicity in older patients with urothelial carcinoma, ...
"The long-term goal is not to merely chase clinical vision measurements. Instead, it is to enable patients to live ...
China has roughly 50 million patients with fundus diseases — a group of conditions that affect the interior surface of the ...
GenSight Biologics SA ( (FR:SIGHT) ) has issued an update.
Mark your calendar for the upcoming Health Fair, Saturday, October 24, 7am to 12 noon at the Pagosa Springs High School. The 4th Annual Health Fair is a community-centered event designed to empower ...
A new museum exhibit exploring the rise and fall of gambling in Hot Springs is set to open at the Old State House Museum ...
GenSight Biologics: Pioneer trial on GS030 published in NEJM, visual signals in 6 out of 10 patients
GenSight Biologics and the National Hospital of 15-20 announced on October 8, 2026 the publication, in The New England ...
A lawsuit alleges inadequate warnings and physician oversight after a man died in 2025 following penis enlargement injections at a Dallas clinic.
Understanding and treating chronic neuropathic pain has remained challenging due to its complex nature. New research from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results